KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Short term Debt: 2019-2025

Historic Short term Debt for Castle Biosciences (CSTL) over the last 2 years, with Jun 2025 value amounting to $1.9 million.

  • Castle Biosciences' Short term Debt was N/A to $1.9 million in Q2 2025 from the same period last year, while for Jun 2025 it was $1.9 million, marking a year-over-year change of. This contributed to the annual value of $278,000 for FY2024, which is N/A change from last year.
  • As of Q2 2025, Castle Biosciences' Short term Debt stood at $1.9 million, which was up 74.98% from $1.1 million recorded in Q1 2025.
  • In the past 5 years, Castle Biosciences' Short term Debt ranged from a high of $20.8 million in Q1 2022 and a low of $278,000 during Q4 2024.
  • In the last 2 years, Castle Biosciences' Short term Debt had a median value of $1.1 million in 2025 and averaged $1.1 million.